• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured

Featured

Most popular
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book ‘The Nature of Drugs’

PTSF49 – MDMA For Alcoholism, The Placebo Effect, and Ceremonial Magicians

PT311 – William Leonard Pickard – LSD, Fentanyl, Prison, and the...

DMT Art: A Look Behind Visionary Creations

Cybin Files its 12th Patent Further Strengthening IP Portfolio of Novel...

Mapping the DMT Experience

Changa vs. DMT: What You Need to Know

Psyence Group Corporate Update

Vital 2024: Informational Session and Q&A

Editor’s Choice Award 2021-Best Study on Psychedelics and Neuroplasticity

Numinus Wellness Commends Health Canada on Special Access Programme Amendments to...

This is the Difference Between Psilocybin and LSD

123...289Page 1 of 289

EDITOR PICKS

Psychedelic Bulletin #200: Can Czechia Deliver on Psilocybin Access? A Closer...

The Backyard Psychedelic Renaissance: How Bottom-Up Change Is Delivering Psychedelic Access

Dreamshadow Transpersonal Breathwork

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©